Biomolecular Target ID and Validation

Our complete application-based solutions can help increase your throughput while simplifying the generation of accurate, reproducible analysis. Providing automated workflow solutions for nucleic acid isolation and PCR setup, NGS sample prep, long-read sequencing, CRISPR fragment analysis, molecular cytogenetics and protein characterization.

Our phenotype-oriented target identification and validation techniques can support direct correlations between genetic alterations and disease phenotypes, reducing the risk of failures at early stages. Combine this with our in vitro and in vivo methods to aid you achieve more accurate prediction of target relevance in human disease. Solutions include cellular imaging for in vitro target validation, in vivo imaging for target discovery, and data capture and analysies via electronic laboratory notebook and data analytic solutions

Providing a range of solutions for high content imaging and analysis and phenotypic screening of live cells, 3D cell models and stem cells.

Modulation of protein interactions can affect signal transduction, growth factor, gene expression, and other factors, making it a promising new avenue for protein-based treatments. Our protein-protein interaction assays support the fast, multimode detection of protein-protein interactions for drug discovery.

Our drug discovery and bioanalytical assays cover a range of assay technologies including our no-wash Alpha and TR-FRET for simple straightforward homogeneous workflows, and our TRF technology offers advantages over traditional ELISAs while maintaining the wash steps.